2024 ICD-10-CM Diagnosis Code B08.04

by

Paravaccinia, unspecified

  • B08.04 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM B08.04 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of B08.04 – other international versions of ICD-10 B08.04 may differ.

The following code(s) above B08.04 contain annotation back-references

 that may be applicable to B08.04:

  • A00-B99  Certain infectious and parasitic diseases
  • B08  Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified
  • B08.0  Other orthopoxvirus infections

ICD-10-CM B08.04 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 865 Viral illness with mcc
  • 866 Viral illness without mcc

Convert B08.04 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Diagnosis Index entries containing back-references to B08.04:

  • Paravaccinia NEC B08.04